Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter, Open-label, Non-interventional Study (NIS) to Evaluate Patient's Satisfaction and Preference, the Usability of DuoResp® SPIROMAX® and the Impact on Clinical Effects, in the Daily Routine of Asthma and COPD Treatment

NCT02384577 is registered in ClinicalTrials.gov with Teva Pharma GmbH as lead sponsor.

NCT NCT02384577
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02384577 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter, Open-label, Non-interventional Study (NIS) to Evaluate Patient's Satisfaction and Preference, the Usability of DuoResp® SPIROMAX® and the Impact on Clinical Effects, in the Daily Routine of Asthma and COPD Treatment
Lead sponsor
Teva Pharma GmbH
Phase
Observational
Overall status
Completed
Start date
July 31, 2014
Completion date
September 30, 2016
Enrollment
4,034 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

patient satisfaction